Structured evidence table for Sulforaphane Cognition Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Sulforaphane Cognition Randomized Trial | The incidence of neurodegenerative diseases is expected to increase rapidly because of increased life expectancy. | 4 | van der Burg Ximaine R. (2026) | Ferroptotic neurodegeneration and diet: a narrative review |
| Sulforaphane Cognition Randomized Trial | Additionally, the total iron content of the hippocampus was reduced through the normalization of the expression of several iron‐homeostasis proteins. | 4 | van der Burg Ximaine R. (2026) | Ferroptotic neurodegeneration and diet: a narrative review |
| Sulforaphane Cognition Randomized Trial | Yang and colleagues concluded that KD activated thepathway, thereby leading to reduced lipid peroxidation and iron accumulation and, thus, preventing ferroptosis. | 4 | van der Burg Ximaine R. (2026) | Ferroptotic neurodegeneration and diet: a narrative review |
| Sulforaphane Cognition Randomized Trial | The association between diet and neurological function has been extensively reported. | 4 | van der Burg Ximaine R. (2026) | Ferroptotic neurodegeneration and diet: a narrative review |
Source documents